ATE416214T1 - Zusammensetzungen enthaltend lipid-polymer konjugate - Google Patents

Zusammensetzungen enthaltend lipid-polymer konjugate

Info

Publication number
ATE416214T1
ATE416214T1 AT02748799T AT02748799T ATE416214T1 AT E416214 T1 ATE416214 T1 AT E416214T1 AT 02748799 T AT02748799 T AT 02748799T AT 02748799 T AT02748799 T AT 02748799T AT E416214 T1 ATE416214 T1 AT E416214T1
Authority
AT
Austria
Prior art keywords
compositions containing
polymer conjugates
containing lipid
poly
amino acid
Prior art date
Application number
AT02748799T
Other languages
English (en)
Inventor
Josbert M Metselaar
Wilhelmus E Hennink
Vringer Tom De
Boer Leonardus W T De
Christien Oussoren
Gerrit Storm
Peter Bruin
Original Assignee
Astellas Pharma Europ B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Europ B V filed Critical Astellas Pharma Europ B V
Application granted granted Critical
Publication of ATE416214T1 publication Critical patent/ATE416214T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/08—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
    • C08G69/10—Alpha-amino-carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Polyamides (AREA)
  • Peptides Or Proteins (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Cosmetics (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Materials For Medical Uses (AREA)
AT02748799T 2001-06-01 2002-06-03 Zusammensetzungen enthaltend lipid-polymer konjugate ATE416214T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01202107 2001-06-01

Publications (1)

Publication Number Publication Date
ATE416214T1 true ATE416214T1 (de) 2008-12-15

Family

ID=8180408

Family Applications (2)

Application Number Title Priority Date Filing Date
AT02748799T ATE416214T1 (de) 2001-06-01 2002-06-03 Zusammensetzungen enthaltend lipid-polymer konjugate
AT02754661T ATE353927T1 (de) 2001-06-01 2002-06-03 Lipid-polymer konjugaten

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT02754661T ATE353927T1 (de) 2001-06-01 2002-06-03 Lipid-polymer konjugaten

Country Status (20)

Country Link
US (3) US20040254352A1 (de)
EP (2) EP1392755B1 (de)
JP (2) JP2004527585A (de)
KR (2) KR100874847B1 (de)
CN (2) CN1271116C (de)
AT (2) ATE416214T1 (de)
BR (2) BR0209699A (de)
CA (2) CA2448856A1 (de)
CZ (2) CZ20033480A3 (de)
DE (2) DE60218154T2 (de)
EE (2) EE200300598A (de)
ES (2) ES2318027T3 (de)
HR (2) HRP20030976A2 (de)
HU (2) HUP0400171A2 (de)
MX (2) MXPA03011050A (de)
NO (2) NO20035263D0 (de)
PL (2) PL369455A1 (de)
SK (2) SK15982003A3 (de)
WO (2) WO2002098952A1 (de)
ZA (2) ZA200308937B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002098952A1 (en) * 2001-06-01 2002-12-12 Yamanouchi Europe B.V. Lipid-polymer-conjugates compositions
FR2840614B1 (fr) 2002-06-07 2004-08-27 Flamel Tech Sa Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques
EP1393720A1 (de) * 2002-08-27 2004-03-03 Universiteit Utrecht Vesikel enthaltend Corticosteroide zur Behandlung von Krebs
SG113442A1 (en) * 2002-11-29 2005-08-29 Agency Science Tech & Res Improved temperature sensitive micelles
FR2855521B1 (fr) 2003-05-28 2005-08-05 Flamel Tech Sa Polyaminoacides fonctionnalises par au moins un groupement h ydrophobe et leurs applications notamment therapeutiques.
EP1481683A1 (de) * 2003-05-30 2004-12-01 Yamanouchi Pharmaceutical Co. Ltd. P-Selectin Zeilgerichtetenligand und dessen Zusammenstezung
SE527505C2 (sv) * 2003-06-10 2006-03-28 Anna Imberg Komposita material och partiklar
FR2860516B1 (fr) * 2003-10-03 2006-01-13 Flamel Tech Sa Homopolyaminoacides telecheliques fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques
CA2651618A1 (en) * 2006-05-09 2007-11-15 Osaka University Cholesterolamine-introduced poly-.gamma.-glutamic acid derivative
JP4936312B2 (ja) * 2006-07-20 2012-05-23 株式会社島津製作所 新規な両親媒性物質、それを用いた薬剤搬送システム及び分子イメージングシステム
JP5258189B2 (ja) * 2006-11-09 2013-08-07 学校法人 関西大学 柔軟性生分解性ポリマー
ITRM20070327A1 (it) * 2007-06-11 2008-12-12 Univ Palermo Vettori colloidali a struttura poliamminoacidica per il rilascio orale di peptidi e proteine e relativo metodo di produzione.
WO2009131672A1 (en) * 2008-04-22 2009-10-29 University Of Massachusetts Stabilized liposome compositions and related methods of use
KR101695836B1 (ko) * 2010-04-13 2017-01-16 (주)아모레퍼시픽 경피흡수용 고분자-리포좀 나노복합체 조성물 및 그 제조방법
ES2385995B2 (es) * 2011-01-10 2013-05-21 Universidade De Santiago De Compostela Nanocápsulas con cubierta polimérica
US9993427B2 (en) * 2013-03-14 2018-06-12 Biorest Ltd. Liposome formulation and manufacture
WO2019172362A1 (ja) * 2018-03-07 2019-09-12 公益財団法人川崎市産業振興財団 刺激応答性ポリマー
JPWO2023282296A1 (de) * 2021-07-07 2023-01-12

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0657722B2 (ja) * 1986-05-27 1994-08-03 三菱化成株式会社 水溶性ポリマ−組成物
US5149794A (en) * 1990-11-01 1992-09-22 State Of Oregon Covalent lipid-drug conjugates for drug targeting
US5395619A (en) * 1993-03-03 1995-03-07 Liposome Technology, Inc. Lipid-polymer conjugates and liposomes
US6333021B1 (en) * 1994-11-22 2001-12-25 Bracco Research S.A. Microcapsules, method of making and their use
US5972379A (en) * 1995-02-14 1999-10-26 Sequus Pharmaceuticals, Inc. Liposome composition and method for administering a quinolone
US6197332B1 (en) * 1997-08-13 2001-03-06 Chiron Corporation Lipid-conjugated polyamide compounds and related compositions and methods thereof
GB9811059D0 (en) * 1998-05-23 1998-07-22 Univ Strathclyde Polyamino acid vesicles
WO2002098952A1 (en) * 2001-06-01 2002-12-12 Yamanouchi Europe B.V. Lipid-polymer-conjugates compositions

Also Published As

Publication number Publication date
JP2004527585A (ja) 2004-09-09
SK15982003A3 (sk) 2004-06-08
NO20035264D0 (no) 2003-11-27
CN1271116C (zh) 2006-08-23
EP1392755A1 (de) 2004-03-03
DE60218154T2 (de) 2007-10-31
DE60230137D1 (de) 2009-01-15
EE200300598A (et) 2004-02-16
KR100874847B1 (ko) 2008-12-19
EP1392755B1 (de) 2008-12-03
CN1602326A (zh) 2005-03-30
DE60218154D1 (de) 2007-03-29
ZA200308937B (en) 2004-11-17
WO2002098951A3 (en) 2003-02-20
WO2002098951A2 (en) 2002-12-12
ES2282439T3 (es) 2007-10-16
CZ20033480A3 (cs) 2004-07-14
WO2002098952A1 (en) 2002-12-12
ES2318027T3 (es) 2009-05-01
CN1520435A (zh) 2004-08-11
CZ20033479A3 (cs) 2004-07-14
PL369455A1 (en) 2005-04-18
EP1392756B1 (de) 2007-02-14
US20040241222A1 (en) 2004-12-02
HUP0400171A2 (en) 2007-02-28
SK15972003A3 (sk) 2004-06-08
NO20035263D0 (no) 2003-11-27
KR20040027512A (ko) 2004-04-01
HUP0400174A2 (en) 2007-02-28
KR100894852B1 (ko) 2009-04-24
MXPA03011049A (es) 2004-06-25
EP1392756A2 (de) 2004-03-03
CA2448856A1 (en) 2002-12-12
EE200300596A (et) 2004-02-16
BR0209699A (pt) 2005-02-01
PL367479A1 (en) 2005-02-21
ATE353927T1 (de) 2007-03-15
CN1308375C (zh) 2007-04-04
US20100145018A1 (en) 2010-06-10
JP2004527586A (ja) 2004-09-09
BR0209695A (pt) 2005-01-11
CA2448858A1 (en) 2002-12-12
HRP20030976A2 (en) 2005-08-31
HRP20030975A2 (en) 2005-08-31
ZA200308938B (en) 2004-11-17
MXPA03011050A (es) 2004-06-25
KR20040027513A (ko) 2004-04-01
US20040254352A1 (en) 2004-12-16

Similar Documents

Publication Publication Date Title
ATE416214T1 (de) Zusammensetzungen enthaltend lipid-polymer konjugate
BR0209431A (pt) Novos compostos de 4-anilinoquinolino-3-carboxamidas
CY1117639T1 (el) Φαρμακευτικες συνθεσεις βασιζομενες επι κρυσταλλικης μορφης i της 5-αζακυτιδινης
CY1107634T1 (el) Φαρμακευτικη συνθεση
CY1117051T1 (el) Φαρμακευτικες συνθεσεις που περιεχουν κρυσταλλικη μορφη (i) της υδροχλωριουχου λερκανιδιπινης
DK1542997T3 (da) Pyrazolylbenzothiazolderivater og deres anvendelse som terapeutiske midler
CO5590918A2 (es) Formulaciones
ATE303149T1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
NO20034660L (no) Spiropyrazolforbindelser, farmasoytiske preparater som omfatter en slik forbindelse, og anvendelse av forbindelsene for fremstilling av farmasoytiske preparater
CY1106076T1 (el) Παραγωγα γλυκοπυρανοσυλοξυβενζυλο βενζολιου και ιατρικες συνθεσεις που πepιεχουν τα ιδια
ATE389635T1 (de) Pharmazeutisch wirksame piperidinderivate
NO20033732L (no) N-substituerte ikke-aryl-heterosykliske NMDA/NR2B-antagonister, og farmasoytiske preparater som omfatter slike forbindelser.
NO20034011D0 (no) Steroider som agonister for FXR
HN2002000247A (es) Derivados de sulfonamida
NO20054787D0 (no) Indenderivater som farmasotiske midler
UY27548A1 (es) Sales de ácido succínico de 5,7,14-triazatetraciclo (10.3.1.02.11.04,9) exadeca-2 (11),3,5,7,9-pentaeno y composiciones farmacéuticas
CR9391A (es) Derivados de indanil-piperazinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
CY1106633T1 (el) Φαρμακευτικες συνθεσεις οι οποιες περιεχουν χαλκο, σαλικυλικο οξυ και βιταμινη c
NO20063293L (no) Farmasoytiske forbindelser
ATE345349T1 (de) Purinderivate
NO20061316L (no) Imidazopyndinderivater som induserbare NO-syntaseinhibitorer
DK1379508T3 (da) N-(aryl)-2arylethensulfonamider og terapeutiske anvendelser deraf
DK1109560T3 (da) Som AICARFT-inhibitorer anvendelige forbindelser
CY1105798T1 (el) Στepοειδη, η παρασκευη τους, φαρμακευτικες συνθεσεις απο αυτα και χρησεις των ενωσεων
DK1180094T3 (da) Kondenserede polycykliske aminosyrer som farmaceutiske midler

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties